Evotec And X-Chem Collaborate To Accelerate Early-Stage Drug Discovery
Portfolio Pulse from Benzinga Newsdesk
Evotec SE and X-Chem have entered a collaboration to enhance early-stage drug discovery using X-Chem's DNA-encoded library technology and Evotec's screening platforms.
September 05, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evotec SE has partnered with X-Chem to leverage DNA-encoded library technology for accelerating early-stage drug discovery, potentially enhancing its drug development capabilities.
The collaboration with X-Chem provides Evotec access to cutting-edge DNA-encoded library technology, which can significantly enhance its drug discovery process. This partnership is likely to improve Evotec's capabilities in identifying potential drug candidates, which is a positive development for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90